COX-2 inhibitors: cancer prevention or cardiovascular risk?

被引：13

|

作者：

Senior, K

机构：

来源：

LANCET ONCOLOGY | 2005年 / 6卷 / 02期

关键词：

D O I：

10.1016/S1470-2045(05)01720-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：68 / 68

页数：1

相关论文

共 50 条

[21] Cox-2 inhibitors - Cardiovascular risk possibly a 'class effect.'
不详
[J]. AMERICAN JOURNAL OF NURSING, 2005, 105 (06) : 30 - 30
[22] COX-2 inhibitors and cardiovascular risk - The data are inconclusive, and these drugs are needed
Lipani, J
[J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (11) : 961 - 962
[23] COX-2, NSAIDs, and cardiovascular risk
McGettigan P.
Henry D.
[J]. Current Cardiovascular Risk Reports, 2007, 1 (4) : 296 - 302
[24] Cardiovascular adverse effects of COX-2 inhibitors
Sharma, JN
[J]. DRUG SAFETY, 2005, 28 (10) : 929 - 929
[25] COX-2 inhibitors in the treatment of cardiovascular disease
Peterson, JC
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 167 (07) : 738 - 739
[26] COX-2 inhibitors and risks for cardiovascular events
Kazuki Takada
[J]. Arthritis Research & Therapy, 3 (1)
[27] COX-2 inhibitors and the thrombotic risk
Schroer, Karsten
Weber, Artur-Aron
[J]. THROMBOSIS AND HAEMOSTASIS, 2006, 96 (04) : 391 - 392
[28] Reduction in the Risk of Human Breast Cancer by COX-2 Inhibitors
Harris, Randall E.
Beebe-Donk, Joanne
Alshafie, Galal A.
[J]. CANCER RESEARCH, 2006, 66 (08)
[29] Use of COX-2 inhibitors and the risk of colorectal cancer.
Coogan, P.
Rosenberg, L.
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S37 - S37
[30] Prevention of colorectal cancer through the use of COX-2 selective inhibitors
Richard M. Peek
[J]. Cancer Chemotherapy and Pharmacology, 2004, 54 : S50 - S56

← 1 2 3 4 5 →